Acute Declines in Estimated Glomerular Filtration Rate in Patients Treated With Benazepril and Hydrochlorothiazide Versus Amlodipine and Risk of Cardiovascular Outcomes.

Elaine Ku Kenneth Jamerson Timothy P Copeland Charles E McCulloch Hocine TighiouartMark J Sarnak

Published in: Journal of the American Heart Association (2024)

Combined use of benazepril and amlodipine remains superior to benazepril and hydrochlorothiazide for cardiovascular outcomes, regardless of the magnitude of the decline in eGFR that occurred with initiation of therapy.

Keyphrases

hypertensive patients
small cell lung cancer
liver failure
epidermal growth factor receptor
tyrosine kinase
blood pressure
drug induced
aortic dissection
stem cells
hepatitis b virus
mesenchymal stem cells
bone marrow